<i>In Vitro</i> Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) <i>Staphylococcus aureus</i> Isolates

<i>In Vitro</i> Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) <i>Staphylococcus aureus</i> Isolates

The high prevalence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infections, always treated with vancomycin and daptomycin, has led to the emergence of vancomycin-intermediate (VISA), heteroresistant vancomycin-intermediate (hVISA) and daptomycin non-susceptible (DNS) <...

Full description

Bibliographic Details
Main Authors: Dafne Bongiorno, Lorenzo Mattia Lazzaro, Stefania Stefani, Floriana Campanile
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Antibiotics
Subjects:
<i>Staphylococcus aureus</i>
MDR-MRSA
dalbavancin
bactericidal activity
refractory clones
Online Access:https://www.mdpi.com/2079-6382/9/12/865

Internet

https://www.mdpi.com/2079-6382/9/12/865

Similar Items